290 related articles for article (PubMed ID: 29189932)
1. Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.
Wu M; Li L; Wang J; Zhang Y; Guo Q; Li X; Zhang X
Eur Radiol; 2018 May; 28(5):2077-2088. PubMed ID: 29189932
[TBL] [Abstract][Full Text] [Related]
2. Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Chen Y; Zhu W; Yi Y; Cao H; Chen F; Zhu Q
Med Ultrason; 2024 Feb; ():. PubMed ID: 38537180
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
Sawatzki M; Meyenberger C; Brand S; Semela D
Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions.
Hu Q; Wang XY; Zhu SY; Kang LK; Xiao YJ; Zheng HY
Acta Radiol; 2015 Jan; 56(1):25-33. PubMed ID: 24436445
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma using contrast-enhanced ultrasound: A systematic review and meta-analysis.
Chen Y; Zhu Y; Chen K; Wang H; Zhang W; Bao J; Wang W
Clin Hemorheol Microcirc; 2021; 79(2):293-309. PubMed ID: 33935070
[TBL] [Abstract][Full Text] [Related]
7. Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis.
Yang Y; Liu C; Yan J; Liu K
Abdom Radiol (NY); 2021 Oct; 46(10):4619-4628. PubMed ID: 34086090
[TBL] [Abstract][Full Text] [Related]
8. Compared with SonoVue
Cao J; Wang H; Ling W
Quant Imaging Med Surg; 2024 Apr; 14(4):2978-2992. PubMed ID: 38617150
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of contrast-enhanced ultrasound to differentiate benign and malignant breast lesions: A systematic review and meta-analysis.
Wang J; Zhao R; Cheng J
Eur J Radiol; 2022 Apr; 149():110219. PubMed ID: 35228171
[TBL] [Abstract][Full Text] [Related]
10. Machine learning for malignant versus benign focal liver lesions on US and CEUS: a meta-analysis.
Campello CA; Castanha EB; Vilardo M; Staziaki PV; Francisco MZ; Mohajer B; Watte G; Moraes FY; Hochhegger B; Altmayer S
Abdom Radiol (NY); 2023 Oct; 48(10):3114-3126. PubMed ID: 37365266
[TBL] [Abstract][Full Text] [Related]
11. The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.
Huang JX; Shi CG; Xu YF; Fu J; Zhong Y; Liu LZ; Pei XQ
Eur Radiol; 2022 Oct; 32(10):6830-6839. PubMed ID: 35881185
[TBL] [Abstract][Full Text] [Related]
12. Prospective assessment of diagnostic efficacy and safety of Sonazoid
Lv K; Zhai H; Jiang Y; Liang P; Xu HX; Du L; Chou YH; Xie X; Luo Y; Lee YJ; Lee JY; Hu B; Luo B; Wang Y; Luan Y; Kalli C; Chen K; Wang W; Liang JD
Abdom Radiol (NY); 2021 Oct; 46(10):4647-4659. PubMed ID: 34136936
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
[TBL] [Abstract][Full Text] [Related]
14. Shear-wave elastography combined with contrast-enhanced ultrasound algorithm for noninvasive characterization of focal liver lesions.
Ruan SM; Huang H; Cheng MQ; Lin MX; Hu HT; Huang Y; Li MD; Lu MD; Wang W
Radiol Med; 2023 Jan; 128(1):6-15. PubMed ID: 36525179
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Contrast-Enhanced Ultrasonography With SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Meta-Analysis.
Lu J; Zhou P; Jin C; Xu L; Zhu X; Lian Q; Gong X
Technol Cancer Res Treat; 2020; 19():1533033820971583. PubMed ID: 33308040
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of three-dimensional contrast-enhanced ultrasound for focal liver lesions: A protocol for systematic review and meta-analysis.
Qu M; Jia Z; Sun L; Wang H
Medicine (Baltimore); 2021 Dec; 100(51):e28147. PubMed ID: 34941062
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis.
Guang Y; Xie L; Ding H; Cai A; Huang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1595-605. PubMed ID: 21850382
[TBL] [Abstract][Full Text] [Related]
19. Comparison of contrast-enhanced ultrasonography with virtual touch tissue quantification in the evaluation of focal liver lesions.
Wu JP; Shu R; Zhao YZ; Ma GL; Xue W; He QJ; Hao MN; Liu Y
J Clin Ultrasound; 2016 Jul; 44(6):347-53. PubMed ID: 26890486
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of contrast-enhanced ultrasound, computed tomography and magnetic resonance imaging for focal liver lesions: a meta-analysis.
Xie L; Guang Y; Ding H; Cai A; Huang Y
Ultrasound Med Biol; 2011 Jun; 37(6):854-61. PubMed ID: 21531500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
